Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

418450

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what criteria NICE has set for new dementia treatments to be recommended for provision by the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	10022
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>The National Institute for Health and Care Excellence assesses significant new drugs and treatments, including those for the treatment of dementia, through its technology appraisal programme. Technology appraisals are conducted in accordance with NICE’s <em>Guide to the methods of technology appraisal 2013</em> which is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/article/pmg9/chapter/Foreword" target="_blank">www.nice.org.uk/article/pmg9/chapter/Foreword</a></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/09/2015 15:15:57 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

418458

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ophthalmic Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the effect of eye clinic liaison officers on improving patient health and social care; and what progress he has made on increasing the provision of such officers.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	9980
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>The Government fully appreciates the impact that sight loss can have on a person’s life and the importance of information being available for those newly diagnosed with sight loss, including signposting patients to appropriate support and rehabilitation services.</p><p> </p><p> </p><p> </p><p>Eye clinics and their staffing, including eye clinic liaison officers, are commissioned and funded by individual clinical commissioning groups on the basis of local assessments of need.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 9977 question first answered 16/09/2015 12:01:58 answering member 1201 label Biography information for Alistair Burt
tabling member	253 label Biography information for Mr Laurence Robertson

418459

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ophthalmic Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding his Department provides for eye clinic liaison officers.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	9977
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>The Government fully appreciates the impact that sight loss can have on a person’s life and the importance of information being available for those newly diagnosed with sight loss, including signposting patients to appropriate support and rehabilitation services.</p><p> </p><p> </p><p> </p><p>Eye clinics and their staffing, including eye clinic liaison officers, are commissioned and funded by individual clinical commissioning groups on the basis of local assessments of need.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 9980 question first answered 16/09/2015 12:01:58 answering member 1201 label Biography information for Alistair Burt
tabling member	253 label Biography information for Mr Laurence Robertson

418462

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Suicide: Males
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of family separation on male suicide rates.
tabling member constituency	Newcastle upon Tyne East
tabling member printed	Mr Nicholas Brown
uin	9993
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>No such assessment has been made, however we know that there are links between mental ill health and social factors like isolation and family breakdown and that men in certain age-groups are more likely to present with suicidal behaviour. Suicide continues to be more than three times as common in males than in females, 13.8 per 100,000 for males in 2011-13, compared to 4.0 for females.</p><p> </p><p><em> </em></p><p> </p><p><em>Preventing suicide in England: A cross-government outcomes strategy to save lives</em>, published in 2012, identified a number of high risk groups who are priorities for prevention young and middle-aged men. The strategy recognises that factors associated with suicide in men include family and relationship problems including marital breakup and social isolation. The strategy recognises that those who work with men in different settings, especially primary care, need to be particularly alert to the signs of suicidal behaviour.</p><p> </p><p> </p><p> </p><p>A review by the Samaritans, <em>Men Suicide and Society</em>, published in 2012, also highlighted that middle-aged men in certain socioeconomic groups are at particularly high risk of suicide. It pointed to evidence that suicidal behaviour results from the interaction of complex factors, including a lack of close social and family relationships, personal crises such as divorce, as well as a general ‘dip’ in subjective wellbeing among people in their mid-years, compared to both younger and older people. The report also found that relationship breakdown is more likely to lead men, rather than women, to suicide and was published in February 2015.</p><p> </p><p> </p><p> </p><p>The Government’s first annual report on the suicide prevention strategy was published on 17 January 2014. It highlighted a new agreement designed to promote greater sharing of information with friends and family of people at risk of suicide. The second annual report into suicide prevention was written for people working in local services.</p><p> </p><p> </p><p> </p><p>In January 2015, this Government called for every part of the National Health Service to commit to a 'zero suicide' ambition to dramatically reduce suicides. This goes beyond health service boundaries into the whole community, bringing in the police, education, housing, debt support services and so on.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 16/09/2015 12:07:20 answering member 1201 label Biography information for Alistair Burt
tabling member	523 label Biography information for Mr Nicholas Brown

418463

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps NHS England takes to assess the health and social care needs of patients with hidradenitis suppurativa; and what assessment he has made of the ability of the NHS to deliver efficient diagnosis and access to specialist care for such patients.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	10010
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10011 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

418464

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what progress has been made by NHS England on the production of a commissioning policy for treatments associated with hidradenitis suppurativa; what the proposed scope of that policy is; and when he expects that policy to have been fully developed.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	10011
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10010 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

418233

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Morquio Syndrome: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects NICE to announce its decision on approving the Vimizim form of elosulfase alfa.
tabling member constituency	Leeds North West
tabling member printed	Greg Mulholland
uin	9950
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) published further draft guidance on 2 September 2015 which recommends elosulphase alfa (Vimizim) for the treatment of mucopolysaccharidosis (type IVA)/Morquio syndrome, subject to certain conditions. Interested parties now have until 23 September to comment on NICE’s draft recommendation.</p><p> </p><p> </p><p> </p><p>NICE now expects to publish its final guidance in January 2016.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/09/2015 11:36:47 answering member 4020 label Biography information for George Freeman
tabling member	1540 label Biography information for Greg Mulholland

418240

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken as a consequence of the roundtable event it co-hosted in February 2015 to explore indepth the issues around the culture of unlicensed and off-label prescriptions.
tabling member constituency	Christchurch
tabling member printed	Mr Christopher Chope
uin	9845
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>The Department and the National Institute for Health and Care Excellence co-hosted a roundtable event to explore in depth the issues around the culture on unlicensed and off-label prescribing in general. Many stakeholders attended this including Breast Cancer Now, Cancer Research UK, Cure Parkinson’s Trust, NHS England and numerous other National Health Service organisations.</p><p> </p><p><strong> </strong></p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/09/2015 10:50:32 answering member 4020 label Biography information for George Freeman
tabling member	242 label Biography information for Sir Christopher Chope

418241

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Royal Bournemouth Hospital: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many vacancies there are for theatre nurses at the Royal Bournemouth Hospital; and if he will discuss with the Home Secretary ensuring that theatre nurses recruited in the Philippines can be employed at that hospital.
tabling member constituency	Christchurch
tabling member printed	Mr Christopher Chope
uin	9846
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>Recruitment is an operational matter for the Foundation Trust.</p><p> </p><p> </p><p> </p><p>We have written to Jane Stitchbury, Chair of the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust informing her of the hon. Member’s enquiry. She will reply shortly and a copy of the letter will be placed in the Library.</p><p> </p><p><strong> </strong></p><p> </p><p>The Secretary of State is keen to ensure that the immigration system works to ensure that the brightest and best candidates from around the world are able to take up posts in NHS trusts where there are no suitable United Kingdom candidates available to take up these positions. The Secretary of State and his officials are in regular contact with Home Office ministers and officials on this and other relevant matters.</p><p> </p><p> </p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 15/09/2015 16:17:18 answering member 3988 label Biography information for Ben Gummer
tabling member	242 label Biography information for Sir Christopher Chope

418242

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Dorset
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what grounds the Clinical Commissioning Group Senate for NHS South West prevent Dorset Clinical Commissioning Group submitting proposals for public consultation on healthcare provision in Dorset.
tabling member constituency	Christchurch
tabling member printed	Mr Christopher Chope
uin	9847
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>We are advised by NHS England that the Dorset Clinical Services Review was considered by the Wessex Clinical Senate as part of the assurance process, with NHS England. The Clinical Senate has acknowledged the scope and volume of the work undertaken by the Dorset Clinical Commissioning Group (CCG) to date, and welcomed the ambition to move care closer to patients’ homes.</p><p> </p><p> </p><p> </p><p>The CCG made the decision to delay the public consultation after reviewing the range of evidence available to it, including findings from the Clinical Senate review, and will undertake further planning and analysis to help set out clearly to the public how it plans to realise its ambitions.</p><p> </p><p> </p><p> </p><p>NHS England will undertake a standard assurance process prior to consultation to ensure proposals are robust, feasible, sustainable, and comply with the four key tests, which are that proposals should demonstrate: support from clinical commissioners; strengthened public and patient engagement; clarity on the clinical evidence base; and support for patient choice.</p><p> </p><p> </p><p> </p><p>We are advised that the CCG plans to publically consult in 2016.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/09/2015 16:01:56 answering member 4020 label Biography information for George Freeman
tabling member	242 label Biography information for Sir Christopher Chope